Free Trial
NASDAQ:SNYR

Synergy CHC Corp. (Uplisting) (SNYR) Stock Price, News & Analysis

$5.43 -0.01 (-0.18%)
(As of 01:23 PM ET)

About Synergy CHC Corp. (Uplisting) Stock (NASDAQ:SNYR)

Key Stats

Today's Range
$5.11
$5.49
50-Day Range
$4.05
$9.01
52-Week Range
$0.12
$10.00
Volume
10,161 shs
Average Volume
20,801 shs
Market Capitalization
$47.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; lifestyle and wellness products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name; products for hands under the Hand MD brand name. The company provides beauty products under the Perfekt Beauty brand; lingerie under Sneaky Vaunt brand; eyelash enhancement products under The Queen Pegasus brand; topical treatments for neuropathic pain under Neuragen brand; and over-the-counter medications under UrgentRx brand. The company sells its products through retailers and television advertising campaigns, as well as skincare products through online. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. The company was incorporated in 2010 and is based in Westbrook, Maine.

Receive SNYR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Synergy CHC Corp. (Uplisting) and its competitors with MarketBeat's FREE daily newsletter.

SNYR Stock News Headlines

Synergy CHC Announces 7th Quarter of Profitability
Is the Trump/Musk duo good for shares of TSLA?
If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.
See More Headlines

SNYR Stock Analysis - Frequently Asked Questions

Synergy CHC Corp. (Uplisting)'s stock was trading at $4.05 at the beginning of the year. Since then, SNYR stock has increased by 26.2% and is now trading at $5.11.
View the best growth stocks for 2024 here
.

Synergy CHC Corp. (Uplisting) (SNYR) raised $10 million in an IPO on Wednesday, October 23rd 2024. The company issued 1,000,000 shares at a price of $9.00-$11.00 per share. Roth Capital Partners acted as the underwriter for the IPO.

Synergy CHC Corp. (Uplisting)'s quiet period expired on Monday, December 2nd. Synergy CHC Corp. (Uplisting) had issued 1,150,000 shares in its initial public offering on October 23rd. The total size of the offering was $10,350,000 based on an initial share price of $9.00. During the company's quiet period, insiders and any underwriters that worked on the IPO were prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Shares of SNYR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Today
12/18/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SNYR
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$26.01 million

Miscellaneous

Free Float
N/A
Market Cap
$44.48 million
Optionable
N/A
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (NASDAQ:SNYR) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners